This inventor holds 8 USPTO granted patents, plus 4 CIPO patents. Top assignees: Centre National De La Recherche Scientifique, Université´ D'aix-Marseille, Basf Se Corporation. Active years: 2015-2026.
Company Filing History:
7 out of 5,383 
3 out of 237 
2 out of 5,893 
Years Active: 2015-2026
Title: Sam Dukan: Innovator in Cell Labeling and Cancer Diagnosis
Introduction
Sam Dukan is a prominent inventor based in Marseilles, France. He has made significant contributions to the field of biotechnology, particularly in the development of methods for labeling eukaryotic cells and diagnosing cancer. With a total of 8 patents to his name, Dukan's work is at the forefront of innovative medical research.
Latest Patents
Dukan's latest patents include groundbreaking methods for labeling eukaryotic cells from multicellular organisms. These methods utilize modified monosaccharide compounds for treating and diagnosing cancer. His inventions also encompass a method for specifically labeling living bacteria using modified non-endogenous monosaccharide compounds. This method involves incubating bacteria with modified compounds that react chemically, allowing for precise labeling and identification of bacterial cells.
Career Highlights
Throughout his career, Sam Dukan has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université d'Aix-Marseille. His research has significantly advanced the understanding of cell labeling techniques and their applications in cancer therapy.
Collaborations
Dukan has collaborated with notable colleagues, including Boris Vauzeilles and Jordi Mas Pons. These partnerships have fostered a collaborative environment that enhances the innovation process in his research endeavors.
Conclusion
Sam Dukan's contributions to biotechnology and cancer research exemplify the impact of innovative thinking in medicine. His patents and collaborative efforts continue to pave the way for advancements in cell labeling and cancer diagnosis.